• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: HOLOGIC, MARLBORUGH MA MYOSURE HYSTEROSCOPIC TISSUE REMOVAL SYSTEM; UTERINE TISSUE REMOVAL SYSTEM

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

HOLOGIC, MARLBORUGH MA MYOSURE HYSTEROSCOPIC TISSUE REMOVAL SYSTEM; UTERINE TISSUE REMOVAL SYSTEM Back to Search Results
Catalog Number 10-401
Device Problem Appropriate Term/Code Not Available (3191)
Patient Problems Hemorrhage/Bleeding (1888); No Code Available (3191)
Event Date 07/08/2016
Event Type  Injury  
Manufacturer Narrative
Lot number of the disposable device not provided by the complainant, therefore the expiration date is not known.Concomitant product(s): serial number of the myosure control unit, hysteroscope and aquilex fluid management system not provided by the complainant.The disposable device is not being returned therefore, a failure analysis of the complaint device cannot be completed.Mfg date: lot number of the disposable device not provided by the complainant, therefore the manufacture date is not known.Device history record (dhr) review was not able to be conducted for the myosure system and the novasure system as the identification numbers were not provided by the complainant.(b)(4).
 
Event Description
Note: this report pertains to the second of two hologic devices used in the same procedure.See associated medwatch, manufacturer's report# 1222780-2016-00195.It was reported a physician performed a myosure procedure for uterine tissue removal and a novasure endometrial ablation on (b)(6) 2016.The physician had difficulty seating the electrode array due to a myoma.The physician removed the novasure device and decided to use the myosure disposable device to cut the myoma.The patient started to bleed heavily.The physician attempted to perform the novasure and received a cavity integrity assessment (cia) test.The procedure was aborted and the physician performed a hysterectomy.The patient was not admitted into the hospital.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
MYOSURE HYSTEROSCOPIC TISSUE REMOVAL SYSTEM
Type of Device
UTERINE TISSUE REMOVAL SYSTEM
Manufacturer (Section D)
HOLOGIC, MARLBORUGH MA
250 campus drive
marlborough MA 01752
Manufacturer Contact
sidra piracha
250 campus drive
marlborough, MA 01752
5082638884
MDR Report Key5846253
MDR Text Key51138757
Report Number1222780-2016-00196
Device Sequence Number1
Product Code HIH
Combination Product (y/n)N
Reporter Country CodeUS
PMA/PMN Number
K100559
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type company representative,health
Reporter Occupation Physician
Type of Report Initial
Report Date 07/08/2016
1 Device was Involved in the Event
1 Patient was Involved in the Event
Date FDA Received08/04/2016
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? No
Device Operator Physician
Device Catalogue Number10-401
Device Lot NumberUNKNOWN
Was Device Available for Evaluation? No
Is the Reporter a Health Professional? Yes
Date Manufacturer Received07/08/2016
Was Device Evaluated by Manufacturer? Device Not Returned to Manufacturer
Is the Device Single Use? Yes
Is This a Reprocessed and Reused Single-Use Device? No
Type of Device Usage Initial
Patient Sequence Number1
Treatment
MYOSURE CONTROL UNIT-SERIAL # UNK
Patient Outcome(s) Required Intervention;
-
-